• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • Myinsights
  • MYBoard
  • Strategy & Consulting
Select Page

Student Advocacy in Pharmacy

by MM360 Staff | May 9, 2025 | Myeloma News

Source: Pharmacy Times articles Student pharmacists can work toward a better future for patients, themselves, and the profession. Read More

Plozasiran Shows Promise as Cholesterol-Lowering Treatment for Mixed Hyperlipidemia

by MM360 Staff | May 9, 2025 | Myeloma News

Source: Pharmacy Times articles Plozasiran shows promise in reducing cholesterol and triglyceride levels in patients with mixed hyperlipidemia and other harmful conditions, addressing significant cardiovascular risks. Read More

Considerations for the Use of Abemaciclib vs Ribociclib in Breast Cancer

by MM360 Staff | May 9, 2025 | Myeloma News

Source: Pharmacy Times articles Abemaciclib and ribociclib have various risks and benefits in treating early breast cancer, highlighting the importance of patient-provider communication. Read More

Breaking New Ground: Emerging Therapies for Treatment of EGFR-Positive NSCLC

by MM360 Staff | May 9, 2025 | Myeloma News

Source: Pharmacy Times articles A panelist discusses how emerging advancements in non–small cell lung cancer (NSCLC) treatment include the anticipated FDA approval of subcutaneous amivantamab, which would significantly reduce infusion-related reactions seen in the...

Vitamin B Supplements Could Aid Glaucoma, Slowing Disease Progression

by MM360 Staff | May 8, 2025 | Myeloma News

Source: Pharmacy Times articles New research reveals that B vitamins and choline may slow glaucoma progression, offering hope for innovative treatments beyond traditional methods. Read More

FDA Approves Avutometinib/Defactinib for Adults With KRAS-Mutated Recurrent LGSOC

by MM360 Staff | May 8, 2025 | Myeloma News

Source: Pharmacy Times articles With this approval, avutometinib/defactinib has become the first and only FDA-approved treatment for patients with recurrent low-grade serous ovarian cancer (LGSOC). Read More
« Older Entries
Next Entries »

Recent Content

  • Expert Shares Key Insights During Melanoma Awareness Month
  • AUC 5 vs AUC 6: MUSC Study Highlights the Tradeoffs in Neoadjuvant Breast Cancer Treatment
  • Understanding AYA Lymphoma Care and Why Treatment May Differ by Age
  • Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium
  • Study Finds Endometriosis May Be Linked to Traumatic Experiences
  • FDA Approves Teal Wand, First At-Home Self-Collection Cervical Cancer Screening Device
  • Eraglusib Combo Improves Survival in Metastatic Pancreatic Cancer
  • A Thank You to Nurses and the Support That Lasts Beyond Cancer Care
  • Study: RSV Vaccine Response in Lung Transplant Recipients
  • Live Zoster Vaccine May Reduce Risk of Cardiovascular Events by 23%, Study Finds
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT